Notify Therapeutics, a biotech company based in Denmark, has raised €5M in funding to advance the development of its innovative non-hormonal fertility treatment. The investment was made by Lundbeckfonden BioCapital and +ND Capital, highlighting their continued commitment to boosting Danish biotech and addressing pressing fertility issues. Founded from research by Professor Karin Lykke-Hartmann into female infertility, Notify Therapeutics is at the forefront…
